Progyny, Inc. (PGNY) stock
PGNYNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 19/304% above fair value
$36.16−0.55 (-1.50%)
Close on Nov 18, 2026Market cap $2.77BP/E 39.3Yield –
Progyny revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Progyny's revenue for the twelve months ending Jun 30, 2026 was $1.31B, up 5.5% year over year. For fiscal 2025 it was $1.29B, up 10.4% from the year before. The highest annual figure on record is $1.29B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.29B | +10.4% |
| FY2024 | Dec 31, 2024 | $1.17B | +7.2% |
| FY2023 | Dec 31, 2023 | $1.09B | +38.3% |
| FY2022 | Dec 31, 2022 | $786.91M | +57.2% |
| FY2021 | Dec 31, 2021 | $500.62M | +45.2% |
| FY2020 | Dec 31, 2020 | $344.86M | +50.1% |
| FY2019 | Dec 31, 2019 | $229.68M | +117.9% |
| FY2018 | Dec 31, 2018 | $105.40M | +116.9% |
| FY2017 | Dec 31, 2017 | $48.58M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $350.51M | +5.3% |
| Q1 FY2026 | Mar 31, 2026 | $328.50M | +1.4% |
| Q4 FY2025 | Dec 31, 2025 | $318.40M | +6.7% |
| Q3 FY2025 | Sep 30, 2025 | $313.35M | +9.3% |
| Q2 FY2025 | Jun 30, 2025 | $332.87M | +9.5% |
| Q1 FY2025 | Mar 31, 2025 | $324.04M | +16.5% |
| Q4 FY2024 | Dec 31, 2024 | $298.43M | +10.6% |
| Q3 FY2024 | Sep 30, 2024 | $286.63M | +2.0% |
| Q2 FY2024 | Jun 30, 2024 | $304.09M | +8.8% |
| Q1 FY2024 | Mar 31, 2024 | $278.08M | +7.6% |
| Q4 FY2023 | Dec 31, 2023 | $269.94M | +26.0% |
| Q3 FY2023 | Sep 30, 2023 | $280.89M | +36.8% |
| Q2 FY2023 | Jun 30, 2023 | $279.37M | +43.3% |
| Q1 FY2023 | Mar 31, 2023 | $258.39M | +50.0% |
| Q4 FY2022 | Dec 31, 2022 | $214.32M | +68.0% |
| Q3 FY2022 | Sep 30, 2022 | $205.37M | +67.9% |
| Q2 FY2022 | Jun 30, 2022 | $195.00M | +51.6% |
| Q1 FY2022 | Mar 31, 2022 | $172.22M | +41.0% |
| Q4 FY2021 | Dec 31, 2021 | $127.55M | +27.2% |
| Q3 FY2021 | Sep 30, 2021 | $122.28M | +23.6% |
| Q2 FY2021 | Jun 30, 2021 | $128.65M | +99.1% |
| Q1 FY2021 | Mar 31, 2021 | $122.13M | +50.7% |
| Q4 FY2020 | Dec 31, 2020 | $100.30M | +54.0% |
| Q3 FY2020 | Sep 30, 2020 | $98.93M | +61.7% |
| Q2 FY2020 | Jun 30, 2020 | $64.61M | +15.0% |
| Q1 FY2020 | Mar 31, 2020 | $81.02M | +71.7% |
| Q4 FY2019 | Dec 31, 2019 | $65.12M | +123.1% |
| Q3 FY2019 | Sep 30, 2019 | $61.20M | +120.1% |
| Q2 FY2019 | Jun 30, 2019 | $56.17M | +114.7% |
| Q1 FY2019 | Mar 31, 2019 | $47.20M | +112.0% |
| Q4 FY2018 | Dec 31, 2018 | $29.19M | – |
| Q3 FY2018 | Sep 30, 2018 | $27.80M | – |
| Q2 FY2018 | Jun 30, 2018 | $26.16M | – |
| Q1 FY2018 | Mar 31, 2018 | $22.26M | – |
See a number that looks wrong?